PTC Therapeutics, Inc. (PTCT)
75.35
-0.09
(-0.12%)
USD |
NASDAQ |
Dec 12, 13:11
PTC Therapeutics Free Cash Flow: 446.25M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Spyre Therapeutics, Inc. | -162.30M |
| Pyxis Oncology, Inc. | -72.45M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -66.30M |
| Cash from Investing (Quarterly) | -289.62M |
| Cash from Financing (Quarterly) | 15.22M |
| Free Cash Flow Per Share (Quarterly) | -3.702 |
| Free Cash Flow to Equity (Quarterly) | -344.46M |
| Free Cash Flow to Firm (Quarterly) | -344.95M |
| Free Cash Flow Yield | 7.20% |